Astrana Health
ASTH
6 hedge funds and large institutions have $1.21M invested in Astrana Health in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.14% more ownership
Funds ownership: 0% → 0.14% (+0.14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$581K |
| 2 |
TA
Tiedemann Advisors
New York
|
+$211K |
| 3 |
Morgan Stanley
New York
|
+$120K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$51.4K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$46.8K |
Top Sellers
ASTH Hedge Fund Activity: Q4 2017 in Review
6 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Astrana Health (ASTH) for Q4 2017, worth a combined $1.21M.
Buyers outnumbered sellers: 6 funds opened new ASTH positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $581K.
- 6 institutional investors held Astrana Health (ASTH) as of Q4 2017, up from 0 in Q3 2017.
- Funds reported $1.21M of Astrana Health stock for Q4 2017.
- 6 funds opened new Astrana Health positions in Q4 2017 and 0 closed out, a net change of +6 holders.
- The largest Astrana Health buyer in Q4 2017 was Millennium Management, an estimated $581K added.
Based on aggregated 13F filings for Q4 2017.